MedPath

Efficacy of delivering the Fear-less Triple P program at two differing levels of intensity for parents of children with anxiety disorders

Not Applicable
Completed
Conditions
Anxiety disorders
Mental Health - Anxiety
Registration Number
ACTRN12615001284550
Lead Sponsor
Vanessa Cobham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
75
Inclusion Criteria

Child aged 7-14 years of age, meeting criteria for at least one clinically significant anxiety disorder (defined as meeting criteria for an anxiety disorder on the Anxiety Disorders Interview Schedule for Children, with a clinical severity rating of at least 4 out of 8).
The only inclusion criteria for parents was that they be able to speak English. Parent age was not seen as relevant.

Exclusion Criteria

Children who are receiving psychological intervention for their anxiety currently or who are taking medication for their anxiety currently.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
% of children free of their primary anxiety diagnosis, as measured on the Anxiety Disorders Interview Schedule for Children.[Post-treatment (1 week following completing of either the workshop or the 6-session standard program); 6-month follow-up (6 months post-completion); and 12-month follow-up (12 months post-completion).<br><br>This change was made prior to any participants commencing in either treatment condition. ]
Secondary Outcome Measures
NameTimeMethod
Scores on the Spence Children's Anxiety Scale, which will be completed by both parents and children.[Post-treatment (1 week following completing of either the workshop or the 6-session standard program); 6-month follow-up (6 months post-completion); and 12-month follow-up (12 months post-completion). <br><br>This change was made prior to any participants commencing in either treatment condition. ];Scores on the Parenting an Anxious Child questionnaire.[Post-treatment (1 week following completing of either the workshop or the 6-session standard program); 6-month follow-up (6 months post-completion); and 12-month follow-up (12 months post-completion). <br><br>This change was made prior to any participants commencing in either treatment condition. ]
© Copyright 2025. All Rights Reserved by MedPath